Merck (MRK) Minority Interest (2009 - 2026)

Merck has disclosed Minority Interest across 18 years of filings, most recently posting $53.0 million for Q1 2026.

• In Q1 2026, Minority Interest fell 18.46% year-over-year to $53.0 million; the TTM figure through Mar 2026 stood at $53.0 million (down 18.46% YoY), while the FY2025 annual figure was $56.0 million, down 5.08% from the prior year.
• Minority Interest slipped to $53.0 million in Q1 2026, from $56.0 million in the prior quarter.
• Over the last five years, Minority Interest for MRK reached as high as $75.0 million in Q2 2022 and fell as low as $49.0 million in Q2 2023.
• The 5-year median for Minority Interest is $60.0 million (2024), against an average of $61.6 million.
• Annual changes were most pronounced in 2023 — Minority Interest tumbled 34.67% — and 2024, when it soared 34.69%.
• A 5-year view of Minority Interest shows it stood at $67.0 million in 2022, then dropped by 19.4% to $54.0 million in 2023, then rose by 9.26% to $59.0 million in 2024, then dropped by 5.08% to $56.0 million in 2025, then dropped by 5.36% to $53.0 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $53.0 million, $56.0 million, and $57.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.